News
Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
18h
MiBolsilloColombia on MSNPBMs on the Senate's Agenda: Obesity Drugs May Be Included in Medicare
The U.S. Congress faces a pivotal moment as it considers a bipartisan health package amidst political polarization. Key ...
WEIGHT loss drugs can sound like a magical quick fix to overeating and constant hunger pangs. But not everyone is eligible ...
More than 1% of U.S. children between the ages of 2 and 18 had “extremely severe obesity” in 2023 — a 250% increase from 2008 ...
A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...
We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results